Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hemoglobin subunit alpha 1 (HBA1) is a critical protein component of the adult hemoglobin tetramer (HbA), which consists of two alpha and two beta subunits. Encoded by the HBA1 gene, this protein is primarily responsible for the transport of oxygen from the lungs to peripheral tissues and the delivery of carbon dioxide back to the lungs. Beyond its primary role in gas exchange, HBA1 has non-canonical functions, such as modulating nitric oxide signaling at myoendothelial junctions to regulate vascular reactivity and exhibiting peroxidase activity. Defects in HBA1, including deletions and point mutations, are the underlying cause of alpha-thalassemia and other hemoglobinopathies, which result in impaired red blood cell function and anemia. In conditions like sickle cell disease, HBA1 is a therapeutic target for drugs such as Voxelotor, which binds to the alpha chain to increase hemoglobin's oxygen affinity and prevent the polymerization of sickle hemoglobin. Emerging therapeutic strategies also include gene-editing technologies like CRISPR to correct genetic defects or reactivate fetal hemoglobin production to compensate for HBA1 deficiency. Additionally, the glycated form of this protein, HbA1c, serves as a vital clinical biomarker for monitoring long-term glycemic control in diabetic patients.
Hemoglobin HbA positive modulator; stabilization of oxygenated hemoglobin state; inhibition of hemoglobin S polymerization
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemoglobin subunit alpha 1 (HBA1).